skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

195 studies were found about Coinfections, Hepatitis C Virus (HCV)

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Condition: HIV; Hepatitis C; HIV and Hepatitis C Coinfection

NCT ID: NCT01335230

Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study

Condition: Acute Hepatitis C; HIV; HIV Infections

NCT ID: NCT00959166

Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV

Condition: Hepatitis B; Hepatitis C; HIV; HIV Infections

NCT ID: NCT00926146

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Condition: Hepatitis C; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00845676

A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis

Condition: Liver Fibrosis; Hepatitis C; HIV; HIV/HCV Co-infection

NCT ID: NCT01707472

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00001117

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Condition: Chronic Hepatitis C Infection in HIV-Infected Persons; HIV Infections

NCT ID: NCT00215891

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00158535

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Condition: Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections

NCT ID: NCT00215839

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00879047

The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals

Condition: Acute Hepatitis C; HIV

NCT ID: NCT01289652

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

Condition: Human Immunodeficiency Virus (HIV); Hepatitis C, Chronic

NCT ID: NCT01206933

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00008463

Control and Eradication Within Australia of Hepatitis C From People Living With HIV

Condition: Hepatitis C; HIV; HIV-HCV Coinfection

NCT ID: NCT02102451

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

Condition: Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; Hepatitis C

NCT ID: NCT02116179

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01285050

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01448915

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

Condition: Chronic Hepatitis C; Hepatitis C; HIV Infections

NCT ID: NCT00736242

Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01147107

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00001035

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection

Condition: Hepatitis C Virus Infection; Human Immunodeficiency Virus Infection; Chronic Hepatitis C; Compensated Cirrhosis and Non-cirrhotics

NCT ID: NCT01939197

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Condition: HIV Infections; Hepatitis C; HCV Infection

NCT ID: NCT00959699

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00018031

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00246363

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Hepatitis C,; Human Immunodeficiency Virus

NCT ID: NCT01667731

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Condition: Hepatitis C Virus; HIV

NCT ID: NCT02073656

Effects of HIV and Hepatitis C Virus on the Brain

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00494936

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00132210

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00037076

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01423643

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00085917

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00530972

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Condition: HIV Infections; Chronic Hepatitis C

NCT ID: NCT00196586

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01105611

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

Condition: Hepatitis C; HIV; Anemia

NCT ID: NCT00315432

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Condition: Hepatitis C, Chronic; HIV Infections

NCT ID: NCT00553930

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

Condition: Hepatitis C, Chronic; Hepacivirus; HIV Infections

NCT ID: NCT00687544

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Condition: HIV Infection; Hepatitis C Infection

NCT ID: NCT00991289

Treatment of Hepatitis C in Hemophilic Patients With HIV

Condition: HIV Infections; Hepatitis C; Hemophilia

NCT ID: NCT00055341

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00296972

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01332955

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00612755

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

Condition: Anemia; Neutropenia; Hepatitis C Virus; HIV Infections

NCT ID: NCT00194857

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Condition: Hepatitis C Infection; HIV Infection

NCT ID: NCT01185028

To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).

Condition: Hepatitis C; HIV Infections; Mental Disorders

NCT ID: NCT00007709

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

Condition: HIV Infections; Hepatitis C Virus

NCT ID: NCT01040039

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection

NCT ID: NCT01006031

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Condition: Hepatitis C Virus; Hiv Infections

NCT ID: NCT00503347

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

Condition: Hepatitis C; HIV Infection

NCT ID: NCT00004846

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00006643

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C; Liver Disease

NCT ID: NCT00078403

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Condition: Chronic HIV Infection; HCV Coinfection

NCT ID: NCT01222611

Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00164060

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

Condition: Human Immunodeficiency Virus Infection; Hepatitis C

NCT ID: NCT01447680

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

Condition: HIV-hepatitis Co-infection; HIV Infections

NCT ID: NCT00662194

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

Condition: Hepatitis C; HIV

NCT ID: NCT01427504

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00015652

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00141284

Injecting Drug Use Community Intervention Trial

Condition: HIV; Hepatitis C; Syphilis; HSV-2; HIV Infections

NCT ID: NCT01108614

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Chronic Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01783678

Study on Immunopathogenesis in HIV and Hepatitis C Coinfection

Condition: HIV Infection; Hepatitis C Infection; Fibrosis; Inflammation

NCT ID: NCT01296529

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Condition: Human Immunodeficiency Virus; Chronic Hepatitis C

NCT ID: NCT00909129

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Condition: Human Immunodeficiency Virus; Hepatitis C

NCT ID: NCT01289951

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Condition: Hepatitis C, Chronic; Human Immunodeficiency Virus

NCT ID: NCT02057003

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Condition: Hepatitis C, Chronic; HIV

NCT ID: NCT01925183

Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00150904

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00470210

Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting

Condition: HIV Infections

NCT ID: NCT00222859

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00121017

Effects of Low-Dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Condition: Hepatitis C; Liver Cirrhosis; HIV Infections

NCT ID: NCT00381017

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00393276

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections

Condition: HIV; Hepatitis C; Liver Disease; Fatty Liver; Steatosis

NCT ID: NCT00742326

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

Condition: Thrombocytopenia; Hepatitis C; HIV Infections

NCT ID: NCT00239733

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00545558

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Condition: HIV; Hepatitis C; Liver Fibrosis

NCT ID: NCT01231685

Brief Intervention for Rural Women at High Risk for HIV/HCV

Condition: Acquired Immune Deficiency Syndrome Virus; Hepatitis C; Drug Abuse

NCT ID: NCT01840722

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00031343

HCV Treatment in HIV Co-Infected Patients in Asia

Condition: Hepatitis C; HIV

NCT ID: NCT01838772

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Condition: HIV; Hepatitis C; Infections

NCT ID: NCT00747539

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Condition: Hepatitis; HIV; Liver Cancer

NCT ID: NCT01350648

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00164372

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01818856

THISTLE - The HIV-HCV Silibinin Trial

Condition: HIV; Hepatitis C

NCT ID: NCT01816490

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Condition: Hepatitis B; Human Immunodeficiency Virus; Hepatitis C, Chronic

NCT ID: NCT00782301

A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Condition: HCV and HIV Seropositive Coinfection

NCT ID: NCT01718301

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Condition: HIV; Hepatitis B; Hepatitis C; Carcinoma, Hepatocellular; AIDS

NCT ID: NCT01790633

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Condition: HIV Infections

NCT ID: NCT00356486

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Condition: HIV-1 and Hepatitis C Co-Infection

NCT ID: NCT00665353

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00023218

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01529073

Trial of Citalopram for the Prevention of Depression

Condition: Depression; HIV Infections; Hepatitis C

NCT ID: NCT00317746

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Condition: HIV; HIV Infections

NCT ID: NCT00358696

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Condition: Non-alcoholic Steatohepatitis; Chronic Liver Disease; HCV; NASH.; HIV Infection; Thrombocytopenia; Hepatitis C Virus; HBV; Human Immunodeficiency Virus; Liver Diseases; Hepatitis B Virus

NCT ID: NCT00678587

Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection

Condition: Hepatitis C; HIV

NCT ID: NCT01182298

VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

Condition: Hepatitis C; HCV; HIV; AIDS

NCT ID: NCT00828789

Dutch Acute HCV in HIV Study (DAHHS)

Condition: Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01912495

Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease

Condition: HIV; Hepatitis C

NCT ID: NCT01654939

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in HIV-1 Infected Patients

Condition: Hepatitis; Hepatitis C; Coinfection HCV and HIV

NCT ID: NCT02103439

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

Brief Intervention for Drug Misuse in the Emergency Department

Condition: Substance Abuse Detection; HIV; Hepatitis B; Hepatitis C; Brief Intervention; HIV Infections

NCT ID: NCT01124591

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Condition: HIV; Hepatitis C

NCT ID: NCT01225705

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Condition: Chronic Hepatitis C; Co-Infection HIV-HCV

NCT ID: NCT00611819

CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01900015

Improving Blood Safety and HIV Testing in Brazil

Condition: HIV; Herpes Simplex 2; Hepatitis C; Hepatitis B; Chagas Disease

NCT ID: NCT01681420

Immune Response to Hepatitis C Virus

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00165919

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Condition: HIV Infections; HCV

NCT ID: NCT00489385

Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus

Condition: Acquired Immune Deficiency Syndrome; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; HIV Infections

NCT ID: NCT00499434

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

ADHEPTA Study: Adherence Questionnaire in Hepatitis C

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT00998621

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Condition: HIV Infections; Liver Toxicity; Hepatitis Co-infection

NCT ID: NCT01273142

Notification of Donors With Positive Microbiology Markers

Condition: Human Immunodeficiency Virus; Hepatitis B; Hepatitis C; Human T-lymphotropic Virus I & II; Creutzfeldt-Jakob Syndrome; HIV Infections

NCT ID: NCT01050881

Study to Reduce Intravenous Exposures (STRIVE)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00391482

Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients

Condition: Hepacivirus; HIV Infections

NCT ID: NCT02008214

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Condition: Liver Diseases, Alcoholic; Alcoholism; HIV; Hepatitis C

NCT ID: NCT01410123

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

Condition: Hepatitis B; Hepatitis C; HIV Infection

NCT ID: NCT00001712

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir

Condition: HIV Infections; HCV Infections

NCT ID: NCT01288417

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Condition: Hepatitis C Virus Genotype-1

NCT ID: NCT01479868

A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Condition: HIV Coinfection

NCT ID: NCT01327547

Leukapheresis for Research on HCV-Coinfected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00076427

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

Condition: Hepatitis C Virus; HIV Infections; Pregnancy

NCT ID: NCT00894257

HIV-HCV Coinfection: Impact of Immune Dysfunction

Condition: HIV Infections; Hepatitis

NCT ID: NCT00575315

An Open Label Trial of Pegylated Interferon, Ribavirin and Telaprevir Versus Pegylated Interferon and Ribavirin Alone in the Treatment of Hepatitis C Genotype 1 Virus Infection in Patients With HIV-1 Co-infection

Condition: HIV

NCT ID: NCT02006745

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Condition: HIV; Hepatitis C; Syphilis; Herpes Simplex Type II

NCT ID: NCT01315054

Effects of Ribavirin on Zidovudine or Stavudine

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00021632

Risk Assessment of Long-Haul Truck Drivers

Condition: Gonorrhea; Chlamydia Infections; Hepatitis B; Hepatitis C; Diabetes Mellitus; Hypertension; Obesity; HIV Infections; Hyperlipidemia

NCT ID: NCT00381992

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition: Hepatitis C

NCT ID: NCT01467479

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Condition: Chronic Hepatitis C

NCT ID: NCT01684787

Increasing Viral Testing in the Emergency Department

Condition: Drug Use; HIV; Hepatitis C

NCT ID: NCT01419899

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Condition: Hepatitis C, Chronic

NCT ID: NCT00353418

Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus

Condition: Hepatitis C, Genotype 1

NCT ID: NCT01471574

Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)

Condition: Hepatitis C

NCT ID: NCT02032888

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Condition: HCV-HIV Co-Infection

NCT ID: NCT01725542

UCLA-Amity Parolee Health Promotion Study

Condition: Hepatitis B; Hepatitis C; HIV; Drug Addiction

NCT ID: NCT01844414

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Condition: Hepatitis C; HIV

NCT ID: NCT01336829

Behavioral Science Aspects of Rapid Test Acceptance

Condition: HIV; Hepatitis C; Hepatitis B; Syphilis

NCT ID: NCT01317784

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

Condition: HIV-HCV Co-infected Patients

NCT ID: NCT01964742

An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus (C-EDGE COINFECTION) (MK-5172-061)

Condition: Chronic Hepatitis C

NCT ID: NCT02105662

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

Condition: Hepatitis c

NCT ID: NCT01472354

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Condition: Hepatitis C; Telaprevir; HIV

NCT ID: NCT00775125

Chronic Hepatitis Intervention Project for Drug Users

Condition: HIV; Hepatitis C

NCT ID: NCT00596843

Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)

Condition: HIV; Hepatitis C

NCT ID: NCT00794391

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Condition: HIV Infection

NCT ID: NCT00234975

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

Condition: HIV Infections

NCT ID: NCT00508222

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients

Condition: HIV Infections

NCT ID: NCT00661349

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Condition: Hepatitis C, Chronic; Co-Infection

NCT ID: NCT01878799

An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users

Condition: Using Cocaine or Heroin in the Last 7 Days,; Age Over 18 Years Old,; Competent to Sign Informed Consent for HIV/HBV/HCV Testing,; HIV/HBV Negatives Will be Randomized for HB Vaccine Study; HIV Infections

NCT ID: NCT00841477

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Condition: Hepatitis C

NCT ID: NCT01647191

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Condition: Acquired Immunodeficiency Syndrome Virus; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; Hepatocellular Carcinoma

NCT ID: NCT02113865

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Condition: Chronic Hepatitis C Infection

NCT ID: NCT01866930

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Condition: Hepatitis C

NCT ID: NCT00857311

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Inmunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Condition: Hepatitis C, Chronic

NCT ID: NCT01399619

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

Prevalence of Liver Fibrosis and Progression of Liver Fibrosis

Condition: HIV Infection and Chronic Alanine Aminotransferase Elevation

NCT ID: NCT01208376

CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01721226

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Condition: Hepatitis C

NCT ID: NCT00703560

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Condition: Hemophilia

NCT ID: NCT00340548

Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men )(MSM) in Two Vietnamese Cities

Condition: HIV; Chlamydia; Gonorrhea; Syphilis; HCV

NCT ID: NCT02122094

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Condition:

NCT ID: NCT00552214

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Condition: Hepatitis

NCT ID: NCT00901524

Influence of Nevirapine on HCV Viral Load

Condition: HCV Infection.; HCV Viral Load.

NCT ID: NCT01277627

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients

Condition: HIV Infection

NCT ID: NCT00190242

S1204, Viral Screening in Newly Diagnosed Cancer Patients

Condition: Cancer

NCT ID: NCT01946516

HIV and HCV Intervention In Drug Treatment Settings - 1

Condition: Behavior Therapy

NCT ID: NCT00102349

A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA

Condition: Healthy Volunteer

NCT ID: NCT00520273

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Condition: Chronic Hepatitis C

NCT ID: NCT00526448

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Condition: HIV Infection; Liver Failure; Evidence of Liver Transplantation

NCT ID: NCT01022476

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Condition: Hepatitis B Virus; HIV

NCT ID: NCT02060162

Reducing Health Problems Associated With Injection Drug Use

Condition: Intravenous Drug Abuse; HIV Infections

NCT ID: NCT01128920

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Condition: Human Immunodeficiency Virus-Infection

NCT ID: NCT01153269

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Condition: Chronic Hepatitis C; Chronic Hepatitis B

NCT ID: NCT00225537

Intensive Models of HCV Care for Injection Drug Users

Condition: Hepatitis C; Medication Adherence

NCT ID: NCT01857245

HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)

Condition: HIV

NCT ID: NCT00339430

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338

The Second Multicenter Hemophilia Cohort Study

Condition: Liver Decompensation; Hepatocellular Carcinoma; Non-Hodgkin Lymphoma

NCT ID: NCT00341705

Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects

Condition: Thalassemia; Sickle Cell Anemia

NCT ID: NCT00971880

Intervention to Reduce Injection Drug Use

Condition: Substance Abuse

NCT ID: NCT00786630

Optimizing Kidney Transplant Informed Consent

Condition: End-stage Kidney Disease

NCT ID: NCT01859884

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

Condition: Healthy

NCT ID: NCT01627717

A Controlled Prospective Study of Transfusion-Associated Hepatitis

Condition: Hepatitis

NCT ID: NCT00004848